The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC. The shake up caps a tumultuous week at the FDA after Marty Makary exited as commissioner just a few days prior.
CNBC’s Angelica Peebles has the details.